-
Je něco špatně v tomto záznamu ?
Achiral and chiral high-performance liquid chromatographic determination of flubendazole and its metabolites in biomatrices using UV photodiode-array and mass spectrometric detection
Nobilis M, Jira T, Lísa M, Holcapek M, Szotáková B, Lamka J, Skálová L.
Jazyk angličtina Země Nizozemsko
Typ dokumentu validační studie
- MeSH
- anthelmintika analýza MeSH
- financování organizované MeSH
- hmotnostní spektrometrie s elektrosprejovou ionizací metody MeSH
- kalibrace MeSH
- mebendazol analogy a deriváty analýza MeSH
- prasata MeSH
- ptáci MeSH
- spektrofotometrie ultrafialová metody MeSH
- stereoizomerie MeSH
- tandemová hmotnostní spektrometrie metody MeSH
- vysokoúčinná kapalinová chromatografie metody MeSH
- zvířata MeSH
- Check Tag
- zvířata MeSH
- Publikační typ
- validační studie MeSH
Flubendazole, methyl ester of [5-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]carbamic acid, belongs to the group of benzimidazole anthelmintics, which are widely used in veterinary and human medicine. The phase I flubendazole biotransformation includes a hydrolysis of the carbamoyl methyl moiety accompanied by a decarboxylation (hydrolysed flubendazole) and a carbonyl reduction of flubendazole (reduced flubendazole). Flubendazole is a prochiral drug, hence a racemic mixture is formed during non-stereoselective reductions at the carbonyl group. Two bioanalytical HPLC methods were developed and validated for the determination of flubendazole and its metabolites in pig and pheasant hepatic microsomal and cytosolic fractions. Analytes were extracted from biomatrices into tert-butylmethyl ether. The first, achiral method employed a 250 mm x 4 mm column with octylsilyl silica gel (5 microm) and an isocratic mobile phase acetonitrile-0.025 M KH(2)PO(4) buffer pH 3 (28:72, v/v). Albendazole was used as an internal standard. The whole analysis lasted 27 min at a flow rate of 1 ml/min. The second, chiral HPLC method, was performed on a Chiralcel OD-R 250 mm x 4.6 mm column with a mobile phase acetonitrile-1 M NaClO(4) (4:6, v/v). This method enabled the separation of both reduced flubendazole enantiomers. The enantiomer excess was evaluated. The column effluent was monitored using a photodiode-array detector (scan or single wavelength at lambda=246 nm). Each of the analytes under study had characteristic UV spectrum, in addition, their chemical structures were confirmed by high-performance liquid chromatography-mass spectrometry (HPLC-MS) experiments. Stereospecificity in the enzymatic carbonyl reduction of flubendazole was observed. While synthetic racemic mixture of reduced flubendazole was separated to equimolar amounts of both enantiomers, practically only one enantiomer was detected in the extracts from all incubates.
- 000
- 00000naa 2200000 a 4500
- 001
- bmc10001275
- 003
- CZ-PrNML
- 005
- 20111210155203.0
- 008
- 100121s2007 ne e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Nobilis, Milan $7 xx0079581
- 245 10
- $a Achiral and chiral high-performance liquid chromatographic determination of flubendazole and its metabolites in biomatrices using UV photodiode-array and mass spectrometric detection / $c Nobilis M, Jira T, Lísa M, Holcapek M, Szotáková B, Lamka J, Skálová L.
- 314 __
- $a Institute of Experimental Biopharmaceutics, Joint Research Center of PRO.MED.CS Praha a.s. and Academy of Sciences of the Czech Republic, Heyrovského, Hradec Králové, Czech Republic. nobilis@uebf.cas.cz <nobilis@uebf.cas.cz>
- 520 9_
- $a Flubendazole, methyl ester of [5-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]carbamic acid, belongs to the group of benzimidazole anthelmintics, which are widely used in veterinary and human medicine. The phase I flubendazole biotransformation includes a hydrolysis of the carbamoyl methyl moiety accompanied by a decarboxylation (hydrolysed flubendazole) and a carbonyl reduction of flubendazole (reduced flubendazole). Flubendazole is a prochiral drug, hence a racemic mixture is formed during non-stereoselective reductions at the carbonyl group. Two bioanalytical HPLC methods were developed and validated for the determination of flubendazole and its metabolites in pig and pheasant hepatic microsomal and cytosolic fractions. Analytes were extracted from biomatrices into tert-butylmethyl ether. The first, achiral method employed a 250 mm x 4 mm column with octylsilyl silica gel (5 microm) and an isocratic mobile phase acetonitrile-0.025 M KH(2)PO(4) buffer pH 3 (28:72, v/v). Albendazole was used as an internal standard. The whole analysis lasted 27 min at a flow rate of 1 ml/min. The second, chiral HPLC method, was performed on a Chiralcel OD-R 250 mm x 4.6 mm column with a mobile phase acetonitrile-1 M NaClO(4) (4:6, v/v). This method enabled the separation of both reduced flubendazole enantiomers. The enantiomer excess was evaluated. The column effluent was monitored using a photodiode-array detector (scan or single wavelength at lambda=246 nm). Each of the analytes under study had characteristic UV spectrum, in addition, their chemical structures were confirmed by high-performance liquid chromatography-mass spectrometry (HPLC-MS) experiments. Stereospecificity in the enzymatic carbonyl reduction of flubendazole was observed. While synthetic racemic mixture of reduced flubendazole was separated to equimolar amounts of both enantiomers, practically only one enantiomer was detected in the extracts from all incubates.
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a anthelmintika $x analýza $7 D000871
- 650 _2
- $a ptáci $7 D001717
- 650 _2
- $a kalibrace $7 D002138
- 650 _2
- $a vysokoúčinná kapalinová chromatografie $x metody $7 D002851
- 650 _2
- $a mebendazol $x analogy a deriváty $x analýza $7 D008463
- 650 _2
- $a hmotnostní spektrometrie s elektrosprejovou ionizací $x metody $7 D021241
- 650 _2
- $a spektrofotometrie ultrafialová $x metody $7 D013056
- 650 _2
- $a stereoizomerie $7 D013237
- 650 _2
- $a prasata $7 D013552
- 650 _2
- $a tandemová hmotnostní spektrometrie $x metody $7 D053719
- 655 _2
- $a validační studie $7 D023361
- 700 1_
- $a Jira, Thomas
- 700 1_
- $a Lísa, Miroslav $7 xx0090411
- 700 1_
- $a Holčapek, Michal, $d 1971- $7 ola2002159192
- 700 1_
- $a Szotáková, Barbora $7 jx20070426012
- 700 1_
- $a Lamka, Jiří, $d 1953- $7 nlk19990073481
- 700 1_
- $a Skálová, Lenka, $d 1965- $7 mzk2004230464
- 773 0_
- $w MED00004968 $t Journal of chromatography. A, Including electrophoresis, mass spectrometry and other separation and detection methods $g Roč. 1149, č. 1 (2007), s. 112-120 $x 0021-9673
- 910 __
- $a ABA008 $b x $y 8
- 990 __
- $a 20090310084605 $b ABA008
- 991 __
- $a 20100425180011 $b ABA008
- 999 __
- $a ok $b bmc $g 707200 $s 569997
- BAS __
- $a 3
- BMC __
- $a 2007 $b 1149 $c 1 $d 112-120 $m Journal of chromatography. A, Including electrophoresis and other separation methods $x MED00004962 $n J Chromatogr A
- LZP __
- $a 2010-b1/ipme